Genomic Health(美國)

Genomic Health

美國GenomicHealthwww.genomichealth.com美國癌癥分子診斷市場第二大廠為GenomicHealth約占美國癌癥分子診斷市場27.7%，且幾乎完全來自乳腺癌市場，它的OncotypeDXR.測試在早期乳腺癌病人中，能預測乳腺癌的續發可能性以及化療的效果，該公司以產品的差異化戰略取得了市場顯著的突破。GenomicHealth,alifesciencecompanyfou ndedinAugustof2000andlocatedinRedwoodCity,California,iscommittedtoimprovingthequalityofcancertreatmentdecisionsthroughtheresearch,developmentandcommercializationofgenomic-basedclinicallaboratoryservices.Tothatend,thecompanyconductssophisticatedgenomicresearchtodevelopclinically-validatedmoleculardiagnosticswhichprovideindividualizedinformationonresponsetocertaintypesoftherapy,aswellasthelikelihoodofdiseaserecurrence.Thesediagnostictechnologiesgenerateinformationthathealthcareprovidersandpatientscanuseinmakingtreatmentdecisions.ThepioneeringworkofGenomicHealthinmoleculardiagnosticshasledtotheOncotypeDXBreastCancerAssay,alaboratorytestthatanalyze